ATC Group: M02AA23 Indometacin

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of M02AA23 in the ATC hierarchy

Level Code Title
1 M Musculo-skeletal system
2 M02 Topical products for joint and muscular pain
3 M02A Topical products for joint and muscular pain
4 M02AA Antiinflammatory preparations, non-steroids for topical use
5 M02AA23 Indometacin

Active ingredients in M02AA23

Active Ingredient Description
Indometacin

Indometacin has anti-inflammatory, antipyretic, and analgesic effects, it is an inhibitor of prostaglandin synthetase.

Related product monographs

Title Information Source Document Type  
INDOCID Capsules Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
INDOCID Suppositories Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicines in this ATC group

Australia (AU)

Austria (AT)

Brazil (BR)

Ecuador (EC)

Estonia (EE)

France (FR)

Hong Kong (HK)

Japan (JP)

Lithuania (LT)

Mexico (MX)

Poland (PL)

Romania (RO)

South Africa (ZA)

Spain (ES)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.